Overview

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

The objective of this study will be to evaluate the safety, tolerability and effect on SOD1 levels by pyrimethamine in patients with familial amyotrophic lateral sclerosis.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Weill Medical College of Cornell University

Collaborator:

Muscular Dystrophy Association

Treatments:

Pyrimethamine